|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4657760A
(en)
|
1979-03-20 |
1987-04-14 |
Ortho Pharmaceutical Corporation |
Methods and compositions using monoclonal antibody to human T cells
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
WO1981001145A1
(en)
|
1979-10-18 |
1981-04-30 |
Univ Illinois |
Hydrolytic enzyme-activatible pro-drugs
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4957939A
(en)
|
1981-07-24 |
1990-09-18 |
Schering Aktiengesellschaft |
Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4472509A
(en)
|
1982-06-07 |
1984-09-18 |
Gansow Otto A |
Metal chelate conjugated monoclonal antibodies
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4474892A
(en)
|
1983-02-16 |
1984-10-02 |
Board Of Trustees Of The Leland Stanford Junior University |
Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US5169774A
(en)
|
1984-02-08 |
1992-12-08 |
Cetus Oncology Corporation |
Monoclonal anti-human breast cancer antibodies
|
|
US4665897A
(en)
|
1984-05-25 |
1987-05-19 |
Lemelson Jerome H |
Composition and method for detecting and treating cancer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
US4938948A
(en)
|
1985-10-07 |
1990-07-03 |
Cetus Corporation |
Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5055459A
(en)
|
1986-06-30 |
1991-10-08 |
Board Of Regents, The University Of Texas |
Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
GB8705477D0
(en)
|
1987-03-09 |
1987-04-15 |
Carlton Med Prod |
Drug delivery systems
|
|
US5223427A
(en)
|
1987-03-31 |
1993-06-29 |
The Scripps Research Institute |
Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
|
|
US4975278A
(en)
|
1988-02-26 |
1990-12-04 |
Bristol-Myers Company |
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5192660A
(en)
|
1989-04-24 |
1993-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
ELISA methods for the determination of human platelet derived growth factor (PDGF) dimer forms present in human tissues and fluids
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
|
US5225212A
(en)
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
EP0747485B1
(en)
|
1989-11-06 |
1998-12-02 |
Cell Genesys, Inc. |
Production of proteins using homologous recombination
|
|
AU635008B2
(en)
|
1989-12-13 |
1993-03-11 |
Genelabs Diagnostics Pte Ltd |
Analytical apparatus and method for automated blot assay
|
|
ATE139258T1
(de)
|
1990-01-12 |
1996-06-15 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6657103B1
(en)
|
1990-01-12 |
2003-12-02 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
JPH049249A
(ja)
|
1990-04-27 |
1992-01-14 |
Kusuda:Kk |
塗型剤吹き付け機
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
AU8507191A
(en)
|
1990-08-29 |
1992-03-30 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5736348A
(en)
|
1990-11-28 |
1998-04-07 |
Fundacao Oswaldo Cruz (Fiocruz) |
Method for the immunological diagnosis of Chagas' Disease using recombinant antigens
|
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
|
GB9114948D0
(en)
|
1991-07-11 |
1991-08-28 |
Pfizer Ltd |
Process for preparing sertraline intermediates
|
|
MX9204374A
(es)
|
1991-07-25 |
1993-03-01 |
Idec Pharma Corp |
Anticuerpo recombinante y metodo para su produccion.
|
|
US6136310A
(en)
|
1991-07-25 |
2000-10-24 |
Idec Pharmaceuticals Corporation |
Recombinant anti-CD4 antibodies for human therapy
|
|
US5756096A
(en)
|
1991-07-25 |
1998-05-26 |
Idec Pharmaceuticals Corporation |
Recombinant antibodies for human therapy
|
|
WO1993010260A1
(en)
|
1991-11-21 |
1993-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
|
JPH05244988A
(ja)
|
1992-03-04 |
1993-09-24 |
Green Cross Corp:The |
抗組織因子モノクローナル抗体、及びこれによる免疫抑制剤
|
|
US5489508A
(en)
|
1992-05-13 |
1996-02-06 |
University Of Texas System Board Of Regents |
Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
|
|
JPH06105910A
(ja)
|
1992-09-30 |
1994-04-19 |
Toyobo Co Ltd |
抗ヌクレオリン抗体吸着材
|
|
DK0752248T3
(da)
|
1992-11-13 |
2000-11-13 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
|
|
EP0744958B1
(en)
|
1994-01-31 |
2003-06-25 |
Trustees Of Boston University |
Polyclonal antibody libraries
|
|
JPH07242566A
(ja)
|
1994-03-01 |
1995-09-19 |
Kirin Brewery Co Ltd |
免疫抑制剤
|
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
|
US5691447A
(en)
|
1995-03-24 |
1997-11-25 |
Tanox Biosystems, Inc. |
GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
AU5632296A
(en)
|
1995-04-27 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6096532A
(en)
|
1995-06-07 |
2000-08-01 |
Aastrom Biosciences, Inc. |
Processor apparatus for use in a system for maintaining and growing biological cells
|
|
EP0883344B2
(en)
|
1995-12-15 |
2010-06-09 |
VIRxSYS Corporation |
Therapeutic molecules generated by trans-splicing
|
|
US5836943A
(en)
|
1996-08-23 |
1998-11-17 |
Team Medical, L.L.C. |
Electrosurgical generator
|
|
US6048703A
(en)
|
1996-11-15 |
2000-04-11 |
Cephalon, Inc. |
Methods for detecting cell apoptosis
|
|
EP2305027B1
(en)
|
1996-12-03 |
2014-07-02 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
CA2284084A1
(en)
|
1997-03-12 |
1998-09-17 |
Institut Pasteur |
A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses
|
|
WO1998055615A1
(en)
|
1997-06-05 |
1998-12-10 |
The University Of Texas Board Or Regents |
Apaf-1, the ced-4 human homolog, an activator of caspase-3
|
|
DE69839147T2
(de)
|
1997-06-12 |
2009-02-19 |
Novartis International Pharmaceutical Ltd. |
Künstliche antikörperpolypeptide
|
|
US6339075B1
(en)
|
1997-06-30 |
2002-01-15 |
The University Of British Columbia |
Use of dextran and other polysaccharides to improve mucus clearance
|
|
AU6053898A
(en)
|
1997-08-04 |
1999-02-22 |
Burnham Institute, The |
A cell-free system of mitochondria-dependent apoptosis, and methods of use ther eof
|
|
US6325785B1
(en)
|
1997-08-14 |
2001-12-04 |
Sherwood Services Ag |
Sputum trap manifold with nested caps
|
|
US5925334A
(en)
|
1997-08-27 |
1999-07-20 |
Rubin; Bruce K. |
Use of surface active agents to promote mucus clearance
|
|
US5932475A
(en)
|
1997-12-12 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Human nucleolin-like protein
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AU762572B2
(en)
|
1998-04-10 |
2003-06-26 |
Chugai Seiyaku Kabushiki Kaisha |
Protein and gene involved in myocyte differentiation
|
|
US6306404B1
(en)
|
1998-07-14 |
2001-10-23 |
American Cyanamid Company |
Adjuvant and vaccine compositions containing monophosphoryl lipid A
|
|
WO2000017648A1
(en)
|
1998-09-24 |
2000-03-30 |
Promega Corporation |
Apoptosis marker antibodies and methods of use
|
|
CA2370000A1
(en)
|
1999-04-08 |
2000-10-19 |
Uab Research Foundation |
Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
|
|
EP1173486A1
(en)
|
1999-04-15 |
2002-01-23 |
Merck Frosst Canada & Co. |
Antibodies that recognize app cleaved by caspases and methods of use
|
|
WO2001022972A2
(en)
|
1999-09-25 |
2001-04-05 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acids
|
|
US6165786A
(en)
*
|
1999-11-03 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of nucleolin expression
|
|
EP1229328B1
(en)
|
1999-11-08 |
2007-06-20 |
Eisai Co., Ltd. |
Method of detecting cell death using cytochrome C.
|
|
JP2001213804A
(ja)
|
2000-01-31 |
2001-08-07 |
Chugai Pharmaceut Co Ltd |
抗組織因子抗体の複合体
|
|
IL151781A0
(en)
|
2000-03-16 |
2003-04-10 |
Genetica Inc |
Methods and compositions for rna interference
|
|
DE60140676D1
(de)
|
2000-03-30 |
2010-01-14 |
Massachusetts Inst Technology |
Mediatoren von rns-interferenz, die rns-sequenzspezifisch sind
|
|
JP2004505894A
(ja)
|
2000-06-02 |
2004-02-26 |
ユニバーシティー オブ コネティカット ヘルス センター |
免疫療法のためのα（２）マクログロブリンと抗原分子との複合体
|
|
US20020028488A1
(en)
|
2000-06-19 |
2002-03-07 |
Sujay Singh |
Transgenic avian species for making human and chimeric antibodies
|
|
EP1170874A1
(de)
*
|
2000-07-05 |
2002-01-09 |
Infineon Technologies AG |
Empfangseinrichtung, insbesondere für den Mobilfunk
|
|
DE10037861A1
(de)
|
2000-08-01 |
2002-02-14 |
Max Delbrueck Centrum |
Mittel zur Therapie maligner Erkrankungen
|
|
EP1311530A4
(en)
|
2000-08-03 |
2004-10-06 |
Wim-Van Schooten |
PRODUCTION OF HUMANIZED ANTIBODIES IN TRANSGENIC ANIMALS
|
|
DE10059821A1
(de)
|
2000-12-01 |
2002-06-13 |
Clariant Gmbh |
Tensidfreie kosmetische, dermatologische und pharmazeutische Mittel
|
|
CZ308053B6
(cs)
|
2000-12-01 |
2019-11-27 |
Max Planck Gesellschaft |
Izolovaná molekula dvouřetězcové RNA, způsob její výroby a její použití
|
|
FR2817875B1
(fr)
|
2000-12-07 |
2005-03-18 |
Technopharm |
Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation
|
|
WO2002059377A2
(en)
|
2001-01-24 |
2002-08-01 |
Protein Design Labs |
Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
|
|
JP3676991B2
(ja)
|
2001-07-05 |
2005-07-27 |
松下電器産業株式会社 |
無線通信装置及び無線通信方法
|
|
DE60208562T2
(de)
|
2001-07-16 |
2006-11-09 |
Arla Foods Amba |
Verfahren zur herstellung von tagatose
|
|
AU2002362436A1
(en)
|
2001-10-03 |
2003-04-14 |
Rigel Pharmaceuticals, Inc. |
Modulators of lymphocyte activation and migration
|
|
US7544767B2
(en)
|
2002-04-05 |
2009-06-09 |
Burnham Institute For Medical Research |
HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
|
|
WO2003087124A2
(en)
|
2002-04-05 |
2003-10-23 |
The Burnham Institute |
Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells
|
|
US7357928B2
(en)
*
|
2002-04-08 |
2008-04-15 |
University Of Louisville Research Foundation, Inc. |
Method for the diagnosis and prognosis of malignant diseases
|
|
US7541150B2
(en)
*
|
2002-04-08 |
2009-06-02 |
University Of Louisville Research Foundation, Inc |
Method for the diagnosis and prognosis of malignant diseases
|
|
ATE458196T1
(de)
|
2002-06-26 |
2010-03-15 |
Univ Louisville Res Found |
Verfahren zum apoptosenachweis
|
|
WO2004030615A2
(en)
|
2002-10-02 |
2004-04-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
GB2398783A
(en)
|
2003-02-26 |
2004-09-01 |
Antonio Lanzavecchia |
A method for producing immortalised human B memory lymphocytes
|
|
WO2004076677A2
(en)
|
2003-02-26 |
2004-09-10 |
Institute For Research In Biomedicine |
Monoclonal antibody production by ebv transformation of b cells
|
|
EP2233926A3
(en)
|
2003-04-01 |
2011-01-12 |
The Johns Hopkins University |
Breast Endothelial Cell Expression Patterns
|
|
NZ587776A
(en)
|
2003-04-09 |
2012-03-30 |
Genentech Inc |
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor using anti-CD20 antibody
|
|
TW200504210A
(en)
|
2003-07-30 |
2005-02-01 |
Chin-Tarng Lin |
A nucleolin antisense inhibiting growth of cancer cell
|
|
US20050187176A1
(en)
|
2003-10-10 |
2005-08-25 |
Bates Paula J. |
Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases
|
|
TW200600784A
(en)
|
2004-06-02 |
2006-01-01 |
Sidney Kimmel Cancer Ct |
Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
|
|
AU2005249540B2
(en)
|
2004-06-02 |
2009-02-19 |
Sidney Kimmel Cancer Center |
Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
|
|
US7494779B2
(en)
|
2004-06-14 |
2009-02-24 |
Li-Te Chin |
Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist
|
|
WO2006050058A2
(en)
|
2004-10-28 |
2006-05-11 |
The General Hospital Corporation |
Methods of detection and therapy of inflamed tissues using immune modulation
|
|
TW200714289A
(en)
|
2005-02-28 |
2007-04-16 |
Genentech Inc |
Treatment of bone disorders
|
|
CN102539734B
(zh)
|
2005-05-12 |
2016-02-03 |
清华大学 |
核仁素辅助的癌症诊断与治疗方法
|
|
ATE509957T1
(de)
|
2005-07-29 |
2011-06-15 |
Life Sciences Res Partners Vzw |
An die a2-domäne bindende, humane inhibitorische anti-faktor-viii-antikörper
|
|
WO2007016466A2
(en)
|
2005-07-29 |
2007-02-08 |
Sloan-Kettering Institute For Cancer Research |
Single wall nanotube constructs and uses therefor
|
|
CA2619784A1
(en)
|
2005-08-23 |
2007-06-07 |
Iq Corporation |
Methods of producing stable b-lymphocytes
|
|
US8933043B2
(en)
*
|
2005-09-30 |
2015-01-13 |
St. Jude Children's Research Hospital |
Methods for regulation of p53 translation and function
|
|
BRPI0619579B8
(pt)
|
2005-12-09 |
2022-01-25 |
Academisch Medisch Centrum Bij De Univ Van Amsterdam |
Métodos para aumentar a expectativa de vida replicativa e/ou estabilidade de uma célula produtora de anticorpo, para expressar um gene de uma célula b codificando a cadeia pesada de ig e/ou cadeia leve de ig, para produzir linhagem de células b, para obter anticorpos, e, método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse
|
|
DK1974020T3
(da)
|
2005-12-16 |
2011-10-03 |
Ribovax Biotechnologies Sa |
Fremgangsmåde til at opnå immortaliserede antistofudskillende celler
|
|
JP2007319153A
(ja)
|
2006-06-02 |
2007-12-13 |
Takashi Otsu |
核酸リガンドと中和剤との組み合わせ製剤
|
|
EP2041570A4
(en)
|
2006-07-12 |
2010-02-24 |
Trellis Bioscience Inc |
CellSpotTM APPLICATIONS
|
|
US7590925B2
(en)
|
2006-09-05 |
2009-09-15 |
Mediatek Inc. |
Apparatus and method for detecting puncture position in a symbol stream encoded by punctured convolutional coding scheme
|
|
MX2009010620A
(es)
|
2007-04-02 |
2009-11-25 |
Genentech Inc |
Marcadores biologicos predictivos de respuesta de artritis reumatoide a antagonistas de celula-b.
|
|
WO2008138017A2
(en)
|
2007-05-08 |
2008-11-13 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for modifying t cell immune responses and inflammation
|
|
EP2006304A1
(en)
|
2007-06-22 |
2008-12-24 |
Stiftung Für Diagnostische Forschung |
Anti-HPA-5b monoclonal antibody
|
|
JP5797403B2
(ja)
*
|
2007-08-03 |
2015-10-21 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
ヒトモノクローナル抗体およびそれを産生する方法
|
|
WO2009043031A2
(en)
|
2007-09-27 |
2009-04-02 |
Children's Medical Center Corporation |
Microbubbles and methods for oxygen delivery
|
|
US20090226914A1
(en)
|
2007-12-31 |
2009-09-10 |
Bates Paula J |
Methods and products to target, capture and characterize stem cells
|
|
US20090215178A1
(en)
|
2008-02-22 |
2009-08-27 |
Zequn Tang |
Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines
|
|
US8231895B2
(en)
|
2008-05-22 |
2012-07-31 |
Universidade De Coimbra |
Targeted delivery to human diseases and disorders
|
|
EP2318439A2
(en)
|
2008-07-23 |
2011-05-11 |
Rappaport Family Institute for Research in the Medical Sciences |
Methods of altering peripheral b cell populations and uses thereof
|
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
|
JP2013508399A
(ja)
|
2009-10-21 |
2013-03-07 |
ヘルス リサーチ インコーポレイテッド |
腫瘍イメージングの増強用のｐａａナノ粒子
|
|
US20110111002A1
(en)
|
2009-11-12 |
2011-05-12 |
Calin Viorel Pop |
Transport and delivery of glutathione into human cells using gold nanoparticles
|
|
JP6174320B2
(ja)
|
2009-11-17 |
2017-08-02 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
ヒトヌクレオリンに対するヒトモノクローナル抗体
|
|
WO2011119058A2
(en)
|
2010-03-22 |
2011-09-29 |
Universidade De Coimbra |
F3-peptide targeted lipid-based nanoparticles useful for the treatment of angiogenesis-dependent diseases
|
|
DK3011974T3
(en)
|
2011-06-02 |
2018-11-12 |
Univ Louisville Res Found Inc |
Anti-nucleolin agent-conjugated nanoparticles
|